These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1908841)

  • 1. HLA class II induction by interferon-gamma in K562 variant cell line: inhibition by serum lipid.
    Ress SR; Rousseau J; Ratanjee B; Eidne K; Millar RP; Keraan M
    Hum Immunol; 1991 May; 31(1):57-66. PubMed ID: 1908841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma.
    Rousset F; Malefijt RW; Slierendregt B; Aubry JP; Bonnefoy JY; Defrance T; Banchereau J; de Vries JE
    J Immunol; 1988 Apr; 140(8):2625-32. PubMed ID: 2965726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
    Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
    J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization.
    Muczynski KA; Anderson SK; Pious D
    J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential induction by immune interferon of the gene products of the HLA-D region on the melanoma cell line MeWo and its metastatic variant MeM 50-10.
    Maio M; Gulwani B; Tombesi S; Langer JA; Duigou GJ; Kerbel RS; Fisher PB; Ferrone S
    J Immunol; 1988 Aug; 141(3):913-20. PubMed ID: 3135316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
    Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E
    Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of MHC class II expression in human cells by dexamethasone.
    Schwiebert LM; Schleimer RP; Radka SF; Ono SJ
    Cell Immunol; 1995 Oct; 165(1):12-9. PubMed ID: 7671315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncoordinate induction and differential regulation of HLA class-I and class-II expression by gamma-interferon in differentiating human neuroblastoma cells.
    Ponzoni M; Guarnaccia F; Corrias MV; Cornaglia-Ferraris P
    Int J Cancer; 1993 Nov; 55(5):817-23. PubMed ID: 8244579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
    Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
    J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of gamma interferon on HLA class-I and -II transcription and protein expression in human breast adenocarcinoma cell lines.
    Jabrane-Ferrat N; Faille A; Loiseau P; Poirier O; Charron D; Calvo F
    Int J Cancer; 1990 Jun; 45(6):1169-76. PubMed ID: 2112515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of class II MHC molecules on human endothelial cells. Effects of IFN and dexamethasone.
    Manyak CL; Tse H; Fischer P; Coker L; Sigal NH; Koo GC
    J Immunol; 1988 Jun; 140(11):3817-21. PubMed ID: 2453556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta 1 modulates the expression of class II histocompatibility antigens on human cells.
    Czarniecki CW; Chiu HH; Wong GH; McCabe SM; Palladino MA
    J Immunol; 1988 Jun; 140(12):4217-23. PubMed ID: 3131428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of interferon-gamma induction of MHC class II and ICAM-1 by a 26-base oligonucleotide composed of deoxyguanosine and deoxythymidine.
    Tam S; Huey B; Li Y; Lui GM; Hwang DG; Lantz M; Weiss TL; Hunt CA; Garovoy MR
    Transpl Immunol; 1994 Dec; 2(4):285-92. PubMed ID: 7704538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
    Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
    J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential susceptibility to modulation by recombinant immune interferon of HLA-DR and -DQ antigens synthesized by melanoma COLO 38 cells.
    Giacomini P; Aguzzi A; Ferrone S
    Hybridoma; 1986; 5(4):277-88. PubMed ID: 3100420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells.
    Maio M; Gulwani B; Morgano A; Ferrone S
    Int J Cancer; 1989 Sep; 44(3):554-9. PubMed ID: 2506138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA antigen expression and malignant mesothelioma.
    Christmas TI; Manning LS; Davis MR; Robinson BW; Garlepp MJ
    Am J Respir Cell Mol Biol; 1991 Sep; 5(3):213-20. PubMed ID: 1910807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of class I and class II histocompatibility antigens on human T cell lines by IFN-gamma.
    Gerrard TL; Dyer DR; Zoon KC; zur Nedden D; Siegel JP
    J Immunol; 1988 May; 140(10):3450-5. PubMed ID: 2966196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
    Shaw AR; Chan JK; Reid S; Seehafer J
    J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA DR, DP, DQ induction in human islet beta cells by the cytokine combination IFN-gamma + TNF-alpha.
    Soldevila G; Doshi M; James R; Lake SP; Sutton R; Gray D; Bottazzo GF; Pujol-Borrell R
    Autoimmunity; 1990; 6(4):307-17. PubMed ID: 2129492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.